Comprehensive In silico Analysis of Single Nucleotide Polymorphisms (SNPs) in Human BDNF Gene

Shovit Ranjan, Praveen Kumar Sharma

Abstract


Since a number of single nucleotide polymorphisms (SNPs) are associated with the BDNF gene mutations involved in different diseases. Hence, it is important to find out the probable functional SNPs before planning a larger population study. So, to look out for the functional nsSNPs (non-synonymous single nucleotide polymorphisms) in BDNF gene, existing data present in the dbSNP database and different bioinformatics tools like SIFT, PolyPhen, nsSNPAnalyzer, F-SNP, I-mutant, Pymol were used for the analysis. The results showed that out of the total 2929 SNPs, 58 were nsSNPs (non-synonymous single nucleotide polymorphisms), 44 occurred in the mRNA 3′ UTR, 108 occurred in 5′ UTR region, 257 occurred in intronic regions and the rest were other types of SNPs. SIFT and PolyPhen programs predicted 3 out of 58 nsSNPs (rs8192466, rs1048218, and rs77787410) as not tolerable, deleterious and damaging. F-SNP revealed that the rs1048221, rs1048220, rs1048218, rs6265 and rs8192466 SNP in the non-synonymous coding region may have protein-coding and splicing regulator functions. PDBSum and UniProtKB predicted the number of protein structures, sharing 100% similarity with the BDNF amino acid sequence. Moreover, I-Mutant and nsSNPAnalyzer showed a decrease in stability for these nsSNPs upon mutation. Protein structural analysis with these amino acid variants was performed by using I-Mutant and PyMOL. This study suggested that three nsSNPs, rs8192466, rs1048218, and rs77787410 were identified as deleterious, thus destabilizing the protein stability, amino acid interactions, and hydrogen bond networks of the protein directly or indirectly. Hence, these SNPs can explain the functional deviation of protein to some extent.

Keywords: BDNF, F-SNP, I-Mutant, nsSNPAnalyzer, PolyPhen, SIFT, SNP


Keywords


BDNF, SNP, SIFT, PolyPhen, nsSNPAnalyzer, F-SNP, I-Mutant

Full Text:

PDF

References


Luu T-D, Rusu A-M, Walter V, et al. MSV3d: database of human MisSense Variants mapped to 3D protein structure. Database. 2012; 2012: bas018.

Smith EP, Boyd J, Frank GR, et al. Estrogen resistance caused by a mutation in the estrogen-receptor gene in a man. New England Journal of Medicine. 1994; 331(16): 1056-61.

Lander ES. The new genomics: global views of biology. Science. 1996; 274(5287): 536.

Barroso I, Gurnell M, Crowley V, et al. Dominant negative mutations in human PPARγ associated with severe insulin resistance, diabetes mellitus and hypertension. Nature. 1999; 402(6764): 880-3.

Chasman D, Adams RM. Predicting the functional consequences of non-synonymous single nucleotide polymorphisms: structure-based assessment of amino acid variation. Journal of molecular biology. 2001; 307(2): 683-706.

Maisonpierre PC, Le Beau MM, Espinosa R, et al. Human and rat brain-derived neurotrophic factor and neurotrophin-3: gene structures, distributions, and chromosomal localizations. Genomics. 1991; 10(3): 558-68.

Fahnestock M, Garzon D, Holsinger R, Michalski B. Neurotrophic factors and Alzheimer’s disease: are we focusing on the wrong molecule? Ageing and Dementia Current and Future Concepts. 2002: 241-52.

Krabbe K, Nielsen A, Krogh-Madsen R, et al. Brain-derived neurotrophic factor (BDNF) and type 2 diabetes. Diabetologia. 2007; 50(2): 431-8.

Oh K-J, Lee DS, Kim WK, Han BS, Lee SC, Bae K-H. Metabolic Adaptation in Obesity and Type II Diabetes: Myokines, Adipokines and Hepatokines. International Journal of Molecular Sciences. 2016; 18(1): 8.

Mogi M, Togari A, Kondo T, et al. Brain-derived growth factor and nerve growth factor concentrations are decreased in the substantia nigra in Parkinson's disease. Neuroscience letters. 1999; 270(1): 45-8.

Parain K, Murer MG, Yan Q, et al. Reduced expression of brain‐derived neurotrophic factor protein in Parkinson's disease substantia nigra. Neuroreport. 1999; 10(3): 557-61.

Connor B, Young D, Yan Q, Faull R, Synek B, Dragunow M. Brain-derived neurotrophic factor is reduced in Alzheimer's disease. Molecular Brain Research. 1997; 49(1): 71-81.

Ferrer I, Marín C, Rey MJ, et al. BDNF and full-length and truncated TrkB expression in Alzheimer disease. Implications in therapeutic strategies. Journal of Neuropathology & Experimental Neurology. 1999; 58(7): 729-39.

Bhagwat M. Searching NCBI's dbSNP database. Current Protocols in Bioinformatics. 2010: 1.19. 1-1.. 8.

Sherry ST, Ward M-H, Kholodov M, et al. dbSNP: the NCBI database of genetic variation. Nucleic acids research. 2001; 29(1): 308-11.

http://www.ncbi.nlm.nih.gov/snp/

Dutta S, Burkhardt K, Bluhm WF, Berman HM. Using the tools and resources of the RCSB Protein Data Bank. Current Protocols in Bioinformatics. 2005.

http://www.rcsb.org/pdb/home/home.do

http://sift.jcvi.org

Ng PC, Henikoff S. SIFT: Predicting amino acid changes that affect protein function. Nucleic acids research. 2003; 31(13): 3812-4.

Ng PC, Henikoff S. Predicting deleterious amino acid substitutions. Genome research. 2001; 11(5): 863-74.

Ng PC, Henikoff S. Predicting the effects of amino acid substitutions on protein function. Annu Rev Genomics Hum Genet. 2006; 7: 61-80.

http://genetics.bwh.harvard.edu/pph2/

Ramensky V, Bork P, Sunyaev S. Human non‐synonymous SNPs: server and survey. Nucleic acids research. 2002; 30(17): 3894-900.

Adzhubei IA, Schmidt S, Peshkin L, et al. A method and server for predicting damaging missense mutations. Nature methods. 2010; 7(4): 248-9.

Boyko AR, Williamson SH, Indap AR, et al. Assessing the evolutionary impact of amino acid mutations in the human genome. PLoS Genet. 2008; 4(5): e1000083.

Rajasekaran R, Sudandiradoss C, Doss CGP, Sethumadhavan R. Identification and in silico analysis of functional SNPs of the BRCA1 gene. Genomics. 2007; 90(4): 447-52.

Bowie JU, Lüthy R, Eisenberg D. A method to identify protein sequences that fold into a known three-dimensional structure. Science. 1991: 164-70.

Prokunina L, Castillejo-López C, Öberg F, et al. A regulatory polymorphism in PDCD1 is associated with susceptibility to systemic lupus erythematosus in humans. Nature genetics. 2002; 32(4): 666-9.

Prokunina L, Alarcón-Riquelme ME. Regulatory SNPs in complex diseases: their identification and functional validation. Expert reviews in molecular medicine. 2004; 6(10): 1-15.

http://compbio.cs.queensu.ca/F-SNP/

Lee PH, Shatkay H. F-SNP: computationally predicted functional SNPs for disease association studies. Nucleic acids research. 2008; 36(suppl 1): D820-D4.

Lee PH, Shatkay H. An integrative scoring system for ranking SNPs by their potential deleterious effects. Bioinformatics. 2009; 25(8): 1048-55.

Laskowski RA. PDBsum: summaries and analyses of PDB structures. Nucleic acids research. 2001; 29(1): 221-2.

Consortium U. UniProt: the universal protein knowledgebase. Nucleic acids research. 2017; 45(D1): D158-D69.

https://www-bimas.cit.nih.gov/molbio/proscan/

Prestridge DS. Predicting Pol II promoter sequences using transcription factor binding sites. Journal of molecular biology. 1995; 249(5): 923-32.

http://www.softberry.com/

Solovyev VV, Shahmuradov IA, Salamov AA. Identification of promoter regions and regulatory sites. Computational Biology of Transcription Factor Binding. 2010: 57-83.

http://www.cbs.dtu.dk/services/Promoter/

Knudsen S. Promoter2. 0: for the recognition of PolII promoter sequences. Bioinformatics. 1999; 15(5): 356-61.

Capriotti E, Fariselli P, Casadio R. I-Mutant2. 0: predicting stability changes upon mutation from the protein sequence or structure. Nucleic acids research. 2005; 33(suppl 2): W306-W10.

Abagyan R, Totrov M. Biased probability Monte Carlo conformational searches and electrostatic calculations for peptides and proteins. Journal of molecular biology. 1994; 235(3): 983-1002.

Schymkowitz J, Borg J, Stricher F, Nys R, Rousseau F, Serrano L. The FoldX web server: an online force field. Nucleic acids research. 2005; 33(suppl 2): W382-W8.

http://prosite.expasy.org/

Sigrist CJ, De Castro E, Cerutti L, et al. New and continuing developments at PROSITE. Nucleic acids research. 2012: gks1067.

DeLano WL. The PyMOL user’s manual. DeLano Scientific, San Carlos, CA. 2002; 452.

DeLano WL. The PyMOL molecular graphics system. 2002.

Xi T, Jones IM, Mohrenweiser HW. Many amino acid substitution variants identified in DNA repair genes during human population screenings are predicted to impact protein function. Genomics. 2004; 83(6): 970-9.




DOI: https://doi.org/10.37591/rrjols.v8i3.1150

Refbacks

  • There are currently no refbacks.